| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DEMANT.CO - | SELL | -2,125 @ DKK 28.3585 | DKK -60,262 | The ETF sold 2125 shares of DEMANT.CO on 2025-12-08. The shares were previously bought for an average price of DKK 32.2794. The shares were sold for -12.1% lower than average price of previous purchases. This resulted in an overall loss of DKK 8,332 (USD $1,299) The average price that the ETF previously sold DEMANT.CO share for is DKK 34.7946 which is higher than the selling price of DKK 28.3585 on 2025-12-08. |
| HIK.L - | SELL | -3,675 @ GBP 17.8874 | GBP -65,736 | The ETF sold 3675 shares of HIK.L on 2025-12-08. The shares were previously bought for an average price of GBP 22.3835. The shares were sold for -20.1% lower than average price of previous purchases. This resulted in an overall loss of GBP 16,523 (USD $22,016) The average price that the ETF previously sold HIK.L share for is GBP 23.628 which is higher than the selling price of GBP 17.8874 on 2025-12-08. |
| GRF.MC - Grifols SA | SELL | -6,525 @ EUR 10.82 | EUR -70,601 | The ETF sold 6525 shares of GRF.MC on 2025-12-08. The shares were previously bought for an average price of EUR 10.6752. The Grifols SA shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of EUR 945 (USD $1,100) The average price that the ETF previously sold GRF.MC share for is EUR 10.2855 so the ETF has sold 6525 shares on 2025-12-08 at a higher price than the previous selling average. |
| BIM.PA - BioMerieux | SELL | -900 @ EUR 104.3 | EUR -93,870 | The ETF sold 900 shares of BIM.PA on 2025-12-08. The shares were previously bought for an average price of EUR 114.199. The BioMerieux shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of EUR 8,909 (USD $10,370) The average price that the ETF previously sold BIM.PA share for is EUR 112.109 which is higher than the selling price of EUR 104.3 on 2025-12-08. |
| TUB.BR - Financiere de Tubize SA | SELL | -450 @ EUR 220.5 | EUR -99,225 | The ETF sold 450 shares of TUB.BR on 2025-12-08. The shares were previously bought for an average price of EUR 210.25. The Financiere de Tubize SA shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of EUR 4,613 (USD $5,369) The average price that the ETF previously sold TUB.BR share for is EUR so the ETF has sold 450 shares on 2025-12-08 at a higher price than the previous selling average. |
| IPN.PA - Ipsen SA | SELL | -825 @ EUR 122.4 | EUR -100,980 | The ETF sold 825 shares of IPN.PA on 2025-12-08. The shares were previously bought for an average price of EUR 110.554. The Ipsen SA shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of EUR 9,773 (USD $11,376) The average price that the ETF previously sold IPN.PA share for is EUR 107.02 so the ETF has sold 825 shares on 2025-12-08 at a higher price than the previous selling average. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | SELL | -2,525 @ EUR 49.1 | EUR -123,978 | The ETF sold 2525 shares of REC.MI on 2025-12-08. The shares were previously bought for an average price of EUR 52.7383. The Recordati Industria Chimica e Farmaceutica SpA shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 9,187 (USD $10,694) The average price that the ETF previously sold REC.MI share for is EUR 51.4609 which is higher than the selling price of EUR 49.1 on 2025-12-08. |
| SOBI.ST - | SELL | -4,325 @ SEK 31.2762 | SEK -135,270 | The ETF sold 4325 shares of SOBI.ST on 2025-12-08. The shares were previously bought for an average price of SEK 26.7864. The shares were sold for 16.8% higher than average price of previous purchases. This sale made a profit of SEK 19,418 (USD $2,066) The average price that the ETF previously sold SOBI.ST share for is SEK 27.0074 so the ETF has sold 4325 shares on 2025-12-08 at a higher price than the previous selling average. |
| DIM.PA - Sartorius Stedim Biotech | SELL | -650 @ EUR 211.5 | EUR -137,475 | The ETF sold 650 shares of DIM.PA on 2025-12-08. The shares were previously bought for an average price of EUR 192.964. The Sartorius Stedim Biotech shares were sold for 9.6% higher than average price of previous purchases. This sale made a profit of EUR 12,048 (USD $14,024) The average price that the ETF previously sold DIM.PA share for is EUR 189.757 so the ETF has sold 650 shares on 2025-12-08 at a higher price than the previous selling average. |
| SRT3.DE - Sartorius AG | SELL | -575 @ EUR 253.3 | EUR -145,648 | The ETF sold 575 shares of SRT3.DE on 2025-12-08. The shares were previously bought for an average price of EUR 217.069. The Sartorius AG shares were sold for 16.7% higher than average price of previous purchases. This sale made a profit of EUR 20,833 (USD $24,250) The average price that the ETF previously sold SRT3.DE share for is EUR 222.132 so the ETF has sold 575 shares on 2025-12-08 at a higher price than the previous selling average. |
| ORNBV.HE - Orion Oyj | SELL | -2,400 @ EUR 60.9 | EUR -146,160 | The ETF sold 2400 shares of ORNBV.HE on 2025-12-08. The shares were previously bought for an average price of EUR 59.669. The Orion Oyj shares were sold for 2.1% higher than average price of previous purchases. This sale made a profit of EUR 2,954 (USD $3,439) The average price that the ETF previously sold ORNBV.HE share for is EUR 53.9577 so the ETF has sold 2400 shares on 2025-12-08 at a higher price than the previous selling average. |
| ERF.PA - Eurofins Scientific SE | SELL | -2,600 @ EUR 57.56 | EUR -149,656 | The ETF sold 2600 shares of ERF.PA on 2025-12-08. The shares were previously bought for an average price of EUR 57.6515. The Eurofins Scientific SE shares were sold for -0.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 238 (USD $277) The average price that the ETF previously sold ERF.PA share for is EUR 53.3901 so the ETF has sold 2600 shares on 2025-12-08 at a higher price than the previous selling average. |
| QIA.DE - QIAGEN NV | SELL | -4,775 @ EUR 39.79 | EUR -189,997 | The ETF sold 4775 shares of QIA.DE on 2025-12-08. The shares were previously bought for an average price of EUR 39.6413. The QIAGEN NV shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of EUR 710 (USD $827) The average price that the ETF previously sold QIA.DE share for is EUR 38.3698 so the ETF has sold 4775 shares on 2025-12-08 at a higher price than the previous selling average. |
| FME.DE - Fresenius Medical Care AG | SELL | -4,850 @ EUR 39.47 | EUR -191,430 | The ETF sold 4850 shares of FME.DE on 2025-12-08. The shares were previously bought for an average price of EUR 45.9708. The Fresenius Medical Care AG shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 31,529 (USD $36,700) The average price that the ETF previously sold FME.DE share for is EUR 47.0364 which is higher than the selling price of EUR 39.47 on 2025-12-08. |
| COLO-B.CO - | SELL | -2,775 @ DKK 75.221 | DKK -208,738 | The ETF sold 2775 shares of COLO-B.CO on 2025-12-08. The shares were previously bought for an average price of DKK 83.2028. The shares were sold for -9.6% lower than average price of previous purchases. This resulted in an overall loss of DKK 22,149 (USD $3,452) The average price that the ETF previously sold COLO-B.CO share for is DKK 88.7864 which is higher than the selling price of DKK 75.221 on 2025-12-08. |
| STMN.SW - | SELL | -2,450 @ CHF 97.3672 | CHF -238,550 | The ETF sold 2450 shares of STMN.SW on 2025-12-08. The shares were previously bought for an average price of CHF 109.888. The shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of CHF 30,676 (USD $38,114) The average price that the ETF previously sold STMN.SW share for is CHF 115.829 which is higher than the selling price of CHF 97.3672 on 2025-12-08. |
| SOON.SW - | SELL | -1,125 @ CHF 213.284 | CHF -239,945 | The ETF sold 1125 shares of SOON.SW on 2025-12-08. The shares were previously bought for an average price of CHF 260.436. The shares were sold for -18.1% lower than average price of previous purchases. This resulted in an overall loss of CHF 53,046 (USD $65,909) The average price that the ETF previously sold SOON.SW share for is CHF 297.513 which is higher than the selling price of CHF 213.284 on 2025-12-08. |
| RO.SW - | SELL | -700 @ CHF 348.835 | CHF -244,185 | The ETF sold 700 shares of RO.SW on 2025-12-08. The shares were previously bought for an average price of CHF 304.239. The shares were sold for 14.7% higher than average price of previous purchases. This sale made a profit of CHF 31,217 (USD $38,787) The average price that the ETF previously sold RO.SW share for is CHF 296.24 so the ETF has sold 700 shares on 2025-12-08 at a higher price than the previous selling average. |
| SN.L - Smith & Nephew PLC | SELL | -17,700 @ GBP 14.4863 | GBP -256,408 | The ETF sold 17700 shares of SN.L on 2025-12-08. The shares were previously bought for an average price of GBP 13.6992. The Smith & Nephew PLC shares were sold for 5.7% higher than average price of previous purchases. This sale made a profit of GBP 13,932 (USD $18,563) The average price that the ETF previously sold SN.L share for is GBP 12.981 so the ETF has sold 17700 shares on 2025-12-08 at a higher price than the previous selling average. |
| SHL.DE - Siemens Healthineers AG | SELL | -7,450 @ EUR 43.32 | EUR -322,734 | The ETF sold 7450 shares of SHL.DE on 2025-12-08. The shares were previously bought for an average price of EUR 47.1994. The Siemens Healthineers AG shares were sold for -8.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 28,902 (USD $33,642) The average price that the ETF previously sold SHL.DE share for is EUR 49.2133 which is higher than the selling price of EUR 43.32 on 2025-12-08. |
| MRK.DE - Merck KGaA | SELL | -2,850 @ EUR 119.1 | EUR -339,435 | The ETF sold 2850 shares of MRK.DE on 2025-12-08. The shares were previously bought for an average price of EUR 117.731. The Merck KGaA shares were sold for 1.2% higher than average price of previous purchases. This sale made a profit of EUR 3,902 (USD $4,540) The average price that the ETF previously sold MRK.DE share for is EUR 124.375 which is higher than the selling price of EUR 119.1 on 2025-12-08. |
| GMAB.CO - | SELL | -1,350 @ DKK 275.284 | DKK -371,633 | The ETF sold 1350 shares of GMAB.CO on 2025-12-08. The shares were previously bought for an average price of DKK 209.088. The shares were sold for 31.7% higher than average price of previous purchases. This sale made a profit of DKK 89,365 (USD $13,928) The average price that the ETF previously sold GMAB.CO share for is DKK 190.903 so the ETF has sold 1350 shares on 2025-12-08 at a higher price than the previous selling average. |
| PHIA.AS - Koninklijke Philips NV | SELL | -16,950 @ EUR 23.3 | EUR -394,935 | The ETF sold 16950 shares of PHIA.AS on 2025-12-08. The shares were previously bought for an average price of EUR 22.3589. The Koninklijke Philips NV shares were sold for 4.2% higher than average price of previous purchases. This sale made a profit of EUR 15,952 (USD $18,568) The average price that the ETF previously sold PHIA.AS share for is EUR 23.0704 so the ETF has sold 16950 shares on 2025-12-08 at a higher price than the previous selling average. |
| FRE.DE - Fresenius SE & Co KGaA | SELL | -9,300 @ EUR 47.65 | EUR -443,145 | The ETF sold 9300 shares of FRE.DE on 2025-12-08. The shares were previously bought for an average price of EUR 42.6885. The Fresenius SE & Co KGaA shares were sold for 11.6% higher than average price of previous purchases. This sale made a profit of EUR 46,142 (USD $53,710) The average price that the ETF previously sold FRE.DE share for is EUR 39.7921 so the ETF has sold 9300 shares on 2025-12-08 at a higher price than the previous selling average. |
| SDZ.SW - | SELL | -9,200 @ CHF 62.7179 | CHF -577,005 | The ETF sold 9200 shares of SDZ.SW on 2025-12-08. The shares were previously bought for an average price of CHF 46.9107. The shares were sold for 33.7% higher than average price of previous purchases. This sale made a profit of CHF 145,426 (USD $180,687) The average price that the ETF previously sold SDZ.SW share for is CHF 42.6468 so the ETF has sold 9200 shares on 2025-12-08 at a higher price than the previous selling average. |
| GALD.SW - | SELL | -3,400 @ CHF 175.163 | CHF -595,554 | The ETF sold 3400 shares of GALD.SW on 2025-12-08. The shares were previously bought for an average price of CHF 132.226. The shares were sold for 32.5% higher than average price of previous purchases. This sale made a profit of CHF 145,986 (USD $181,383) The average price that the ETF previously sold GALD.SW share for is CHF 108.298 so the ETF has sold 3400 shares on 2025-12-08 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -2,775 @ EUR 248.2 | EUR -688,755 | The ETF sold 2775 shares of UCB.BR on 2025-12-08. The shares were previously bought for an average price of EUR 189.972. The UCB SA shares were sold for 30.7% higher than average price of previous purchases. This sale made a profit of EUR 161,583 (USD $188,087) The average price that the ETF previously sold UCB.BR share for is EUR 174.013 so the ETF has sold 2775 shares on 2025-12-08 at a higher price than the previous selling average. |
| ALC.SW - | SELL | -11,000 @ CHF 68.4041 | CHF -752,445 | The ETF sold 11000 shares of ALC.SW on 2025-12-08. The shares were previously bought for an average price of CHF 73.8693. The shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of CHF 60,117 (USD $74,695) The average price that the ETF previously sold ALC.SW share for is CHF 79.2328 which is higher than the selling price of CHF 68.4041 on 2025-12-08. |
| BAYN.DE - Bayer AG | SELL | -21,625 @ EUR 34.87 | EUR -754,064 | The ETF sold 21625 shares of BAYN.DE on 2025-12-08. The shares were previously bought for an average price of EUR 25.5091. The Bayer AG shares were sold for 36.7% higher than average price of previous purchases. This sale made a profit of EUR 202,429 (USD $235,632) The average price that the ETF previously sold BAYN.DE share for is EUR 22.0354 so the ETF has sold 21625 shares on 2025-12-08 at a higher price than the previous selling average. |
| HLN.L - Haleon PLC | SELL | -195,575 @ GBP 4.0951 | GBP -800,899 | The ETF sold 195575 shares of HLN.L on 2025-12-08. The shares were previously bought for an average price of GBP 4.39824. The Haleon PLC shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of GBP 59,287 (USD $78,997) The average price that the ETF previously sold HLN.L share for is GBP 4.58829 which is higher than the selling price of GBP 4.0951 on 2025-12-08. |
| LONN.SW - | SELL | -1,550 @ CHF 584.16 | CHF -905,448 | The ETF sold 1550 shares of LONN.SW on 2025-12-08. The shares were previously bought for an average price of CHF 603.713. The shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of CHF 30,307 (USD $37,654) The average price that the ETF previously sold LONN.SW share for is CHF 586.746 which is higher than the selling price of CHF 584.16 on 2025-12-08. |
| ARGX.BR - Argenx SE | SELL | -1,350 @ EUR 783.6 | EUR -1,057,860 | The ETF sold 1350 shares of ARGX.BR on 2025-12-08. The shares were previously bought for an average price of EUR 585.67. The Argenx SE shares were sold for 33.8% higher than average price of previous purchases. This sale made a profit of EUR 267,206 (USD $311,033) The average price that the ETF previously sold ARGX.BR share for is EUR 553.76 so the ETF has sold 1350 shares on 2025-12-08 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -89,250 @ GBP 20.8477 | GBP -1,860,657 | The ETF sold 89250 shares of GSK.L on 2025-12-08. The shares were previously bought for an average price of GBP 17.4295. The GlaxoSmithKline PLC shares were sold for 19.6% higher than average price of previous purchases. This sale made a profit of GBP 305,074 (USD $406,500) The average price that the ETF previously sold GSK.L share for is GBP 16.8003 so the ETF has sold 89250 shares on 2025-12-08 at a higher price than the previous selling average. |
| EL.PA - EssilorLuxottica SA | SELL | -6,600 @ EUR 303.2 | EUR -2,001,120 | The ETF sold 6600 shares of EL.PA on 2025-12-08. The shares were previously bought for an average price of EUR 263.173. The EssilorLuxottica SA shares were sold for 15.2% higher than average price of previous purchases. This sale made a profit of EUR 264,178 (USD $307,506) The average price that the ETF previously sold EL.PA share for is EUR 255.869 so the ETF has sold 6600 shares on 2025-12-08 at a higher price than the previous selling average. |
| SAN.PA - Sanofi SA | SELL | -24,250 @ EUR 83.6 | EUR -2,027,300 | The ETF sold 24250 shares of SAN.PA on 2025-12-08. The shares were previously bought for an average price of EUR 87.044. The Sanofi SA shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of EUR 83,517 (USD $97,215) The average price that the ETF previously sold SAN.PA share for is EUR 92.5159 which is higher than the selling price of EUR 83.6 on 2025-12-08. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -70,725 @ DKK 40.034 | DKK -2,831,405 | The ETF sold 70725 shares of NOVO-B.CO on 2025-12-08. The shares were previously bought for an average price of DKK 54.3016. The Novo Nordisk A/S shares were sold for -26.3% lower than average price of previous purchases. This resulted in an overall loss of DKK 1,009,076 (USD $157,266) The average price that the ETF previously sold NOVO-B.CO share for is DKK 57.3215 which is higher than the selling price of DKK 40.034 on 2025-12-08. |
| NOVN.SW - | SELL | -41,750 @ CHF 113.552 | CHF -4,740,796 | The ETF sold 41750 shares of NOVN.SW on 2025-12-08. The shares were previously bought for an average price of CHF 104.297. The shares were sold for 8.9% higher than average price of previous purchases. This sale made a profit of CHF 386,396 (USD $480,082) The average price that the ETF previously sold NOVN.SW share for is CHF 100.16 so the ETF has sold 41750 shares on 2025-12-08 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -15,425 @ CHF 338.293 | CHF -5,218,170 | The ETF sold 15425 shares of ROG.SW on 2025-12-08. The shares were previously bought for an average price of CHF 288.914. The shares were sold for 17.1% higher than average price of previous purchases. This sale made a profit of CHF 761,671 (USD $946,366) The average price that the ETF previously sold ROG.SW share for is CHF 280.296 so the ETF has sold 15425 shares on 2025-12-08 at a higher price than the previous selling average. |
| AZN.L - AstraZeneca PLC | SELL | -34,050 @ GBP 155.49 | GBP -5,294,435 | The ETF sold 34050 shares of AZN.L on 2025-12-08. The shares were previously bought for an average price of GBP 132.331. The AstraZeneca PLC shares were sold for 17.5% higher than average price of previous purchases. This sale made a profit of GBP 788,564 (USD $1,050,742) The average price that the ETF previously sold AZN.L share for is GBP 127.238 so the ETF has sold 34050 shares on 2025-12-08 at a higher price than the previous selling average. |